Table 2 GNRs as radiosensitizers in radiation therapy
From: Preparation, toxicity reduction and radiation therapy application of gold nanorods
Nanocomposite | Cell line | Tumor model | Radiation/radiation source | Refs. |
|---|---|---|---|---|
GNRs@mSiO2-RGD | MDA-MB-231 | Orthotopic transplantation nude mice models with human TNBC | X-ray | [53] |
RGD-GNRs | A375 | / | X-ray | [63] |
Goserelin-conjugated GNRs | PC3 | Subcutaneous mice models with prostate cancer | X-ray | [64] |
Goserelin-conjugated GNRs | PC3 | Swiss nude mice bearing subcutaneous human prostate cancer | X-ray | [65] |
RGD- and ACPP coated core–shell Au@Se nanocomposite | A375 | Subcutaneous nude mouse models with A375 cancer | X-ray | [66] |
PEG-coated GNRs | KB | / | X-ray | [67] |
GNR-SphK1 siRNA | SCC-15; USC HN-1 | Male Balb/C athymic mice bearing USC HN-1 xenografts | Cs-137 gamma ray | [71] |
AuNR@MS nanostructure | CT-26 cells | / | Co-60 gamma ray | [72] |
PEG-GNRs | / | Athymic Nu/Nu female mice bearing DU-145 prostate tumor | 90Y | [39] |
GNRs@SiO2-FA | HepG2 | / | 125I | [73] |